Peninsula drug maker to pay $360M to settle Justice Department claims

Actelion Pharmaceuticals US Inc. will pay $360 million to settle U.S. Department of Justice claims that the company illegally funded a foundation and steered Medicare customers to the foundation, leaving taxpayers to pick up much of the cost as it hiked prices for its pulmonary arterial hypertension drugs. Arrangements between drug makers and nonprofit foundations, which cover a portion of drug costs, have gained attention over the past couple of years. Pfizer Inc. (NYSE: PFE), for example, paid…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news